Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maldives.
Press releases published on September 22, 2025
September 22, 2025
Medtech Leader Erica Rogers Joins Ceribell Board of Directors
Indeterminate
GlobeNewswire
September 22, 2025
Biognosys to Launch Metabolomics/Lipidomics Services for Multiomics Drug Discovery and Clinical Research
Indeterminate
GlobeNewswire
September 22, 2025
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Vuong Trieu, CEO of Oncotelic Therapeutics Inc.
Indeterminate
GlobeNewswire
September 22, 2025
Picard Advances Patent Protection for Fully Implantable Artificial Heart Technology
Indeterminate
GlobeNewswire
September 22, 2025
Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ESMO 2025
Indeterminate
GlobeNewswire
September 22, 2025
Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
Indeterminate
GlobeNewswire
September 22, 2025
electroCore’s Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire’s 2025 Sleep Awards
Indeterminate
GlobeNewswire
September 22, 2025
Idebenone Accepted by FDA for Priority Review for Leber Hereditary Optic Neuropathy (LHON)
Indeterminate
GlobeNewswire
September 22, 2025
First-Ever EHR-Linked Devices Supercharge Timelier, Personalized Care
Indeterminate
GlobeNewswire
September 22, 2025
ORYZON to Sponsor First Phelan-McDermid Syndrome (PMS) Burden of Illness Study
Indeterminate
GlobeNewswire
September 22, 2025
Connect Names Gretel von Son as Chief Operating Officer to Drive Growth in Entrepreneurship and Innovation
Indeterminate
GlobeNewswire
September 22, 2025
Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting
Indeterminate
GlobeNewswire
September 22, 2025
Immutep Announces Research Collaboration with the George Washington University Cancer Center to Evaluate Neoadjuvant Efti
Indeterminate
GlobeNewswire
September 22, 2025
MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)
Indeterminate
GlobeNewswire
September 22, 2025
ProPhase Continues its Exploration of a Crypto Treasury Strategy
Indeterminate
GlobeNewswire